Ernexa Therapeutics Inc. quarterly report, Q1 FY2015

Filing summary

Issuer identity: The supplied filing is NTN Buzztime, Inc.’s Form 10-Q, not a filing for Ernexa Therapeutics Inc. The financial information below pertains to NTN Buzztime.

Business context and reporting period

The unaudited report covers the quarter ended March 31, 2015, compared with the three months ended March 31, 2014. NTN Buzztime provides interactive entertainment and marketing services to hospitality venues through its Classic and BEOND platforms. It reported approximately 2,908 subscribing venues, with about 43% using BEOND.

Financial performance and liquidity

MetricQ1 2015Q1 2014 / comparison
Revenue$5.726 million$6.418 million; down 11%
Gross profit and margin$3.077 million; 54%$3.888 million; 61%
Operating loss$2.206 million$0.654 million
Net loss$2.263 million; $0.02 per share$0.649 million; $0.01 per share
EBITDA, non-GAAP$(1.446) million$0.070 million
Operating cash flow$0.995 million provided$0.453 million used
Cash and cash equivalents$7.163 million at March 31$7.185 million at December 31, 2014
Working capital$4.981 million$7.779 million at December 31, 2014
Notes payable$4.695 million outstanding$5.319 million at December 31, 2014

Investing cash outflow was $0.437 million and financing cash outflow was $0.632 million. Cash declined $0.022 million during the quarter. Current assets were $12.648 million against current liabilities of $7.667 million.

Material changes versus prior year

  • Subscription revenue fell $0.419 million, primarily due to fewer average subscriber sites and lower average revenue per unit. Total sites declined to 2,908 from 3,145 a year earlier.
  • Sales-type lease revenue declined $0.273 million. Management noted that these equipment lease payments are generally one-time amounts covering three-year leases and may fluctuate as venues convert to BEOND.
  • Gross margin fell seven percentage points, principally due to BEOND tablet and production costs, including approximately $0.162 million of scrapped materials.
  • Operating expenses rose $0.860 million. SG&A increased $0.772 million, including higher payroll and marketing, partly offset by lower professional fees.
  • Operating cash flow improved year over year, helped by customer collections, including approximately $1.558 million due from the prior quarter, and fewer purchases of site equipment to be installed.

Outlook, risks, and unusual items

  • Management said cash and available credit facilities were expected to cover operating requirements and debt obligations for at least the next 12 months, while cautioning that additional financing might be unavailable on acceptable terms if needed.
  • On April 14, 2015, after quarter-end, the company entered a revolving credit facility with East West Bank of up to the lesser of $7.5 million or its borrowing base, with a possible lender-approved increase of up to $2.5 million. It borrowed $3.5 million in April, intended for debt repayment, strategic growth initiatives, and working capital. The facility is secured by company personal property and includes EBITDA and churn covenants.
  • A single customer group, Buffalo Wild Wings corporate-owned restaurants and franchisees, generated 42% of Q1 2015 revenue, versus 41% a year earlier.
  • The company disclosed dependence on suppliers for BEOND tablets and related equipment, with no alternative source for certain components or assembly. Other cited risks include intense competition, technology changes, intellectual property protection, and the ability to grow subscription revenue or raise capital.
  • Management reported no material changes to previously disclosed risk factors, no legal proceedings, and no material changes in internal control over financial reporting. Disclosure controls were assessed as effective.
  • No specific revenue or earnings guidance was provided. Management said lower revenue per unit was expected to be offset by premium services in the future; this was an expectation, not quantified guidance.

Important facts for investors to verify

  • Confirm issuer identity: this filing is for NTN Buzztime, Inc., not Ernexa Therapeutics Inc.
  • Review the East West Bank facility’s borrowing-base availability, covenant thresholds, collateral terms, and compliance after the April borrowing.
  • Assess whether the decline in sites, subscription revenue, and gross margin continued after Q1, and whether BEOND premium services offset lower revenue per unit.
  • Monitor Buffalo Wild Wings’ contribution to revenue and the company’s reliance on limited equipment suppliers.
  • Reconcile the improvement in operating cash flow with the quarter’s net loss and the working-capital decline.